ClinicalTrials.gg
Not yet recruitingNCT06722833Updated Dec 9, 2024

Physiotherapy Investigation in Patient With Temporomandibular Joint Dysfunction

An observational study in Temporomandibular Disorders (TMD), sponsored by Uskudar University. Not yet recruiting. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2024-12-09.

Sponsored by Uskudar University · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 5 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
70
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Knowing the associated factors for people suffering from TMD may help to develop preventive, therapeutic and health strategies. The aim of this study was to present the assessments of audiovestibular symptoms in people with TMD. The main question it aims to answer is the questions are as follows:

1. Is there a relationship between TMJ symptoms and audiovestibular assessment in people with TMD?

Participants will:

Participants diagnosed with TMD will be informed about the study and informed consent will be obtained. Data obtained after the TMJ and vestibular system evaluation of the participants will be analyzed.

Read the detailed description

Temporomandibular dysfunction (TMD) is a health condition affecting the temporomandibular joint (TMJ) and related structures. The prevalence of TMD in adults affects a very large portion of the world's population. TMD is complex and multifactorial due to its etiology with neuromuscular, traumatic, degenerative and sociodemographic aspects. The aim of this study is to reveal audiovestibular assessments in individuals with TMD. After obtaining voluntary consent forms, participants are subjected to assessments. The "Statistical Package for Social Sciences (SPSS) Statistics 23.0 (SPSS Inc, Chicago, USA) program will be used in the analysis of the study data. Before starting the analysis of the data, the Kolmogorv Smirnov test will be used to check whether the data is suitable for normal distribution. Data that are suitable for normal distribution will be analyzed with parametric tests, and those that are not suitable for normal distribution will be analyzed with non-parametric tests. Descriptive statistics for quantitative variables will be shown as mean and standard deviation, and for qualitative variables determined by counting, descriptive statistics will be shown as numbers and percentages. T-test/chi square/Mann Whitney U will be used in two-group comparisons, and one-way variance analysis/Kruskal Wallis test will be used in three-group comparisons.

02

Conditions studied

  • Temporomandibular Disorders (TMD)

Keywords

  • temporomandibular dysfunction
  • pain
03

In context

Temporomandibular Joint Disorders

621 studies on the registry are indexed under Temporomandibular Joint Disorders; 161 are open to participants now.

This study's planned enrollment of 70 is below the median of 90 across 171 observational studies indexed under Temporomandibular Joint Disorders.

Browse Temporomandibular Joint Disorders studies →

Lead sponsor

Uskudar University is the lead sponsor of 168 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Young adults diagnosed with TMD

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Volunteer to participate in the study between the ages of 18-35
  • Diagnosed with unilateral TMJ disorder at least 1 month ago according to the - Research Diagnostic Criteria of Temporomandibular Disorders (RDC/TMD) classification (Dworkin et al., 1992)
  • Having muscle tenderness and pain in the temporomandibular joint region

Exclusion criteria

Exclusion Criteria:

  • Traumatic injuries in the same area other than TMD
  • Ear diseases that cause hearing loss
  • Dentofacial Anomalies
  • Receiving orthodontic treatment
  • Neurological diseases, vestibular or visual problems
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
70 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Visual Analog Scale

    Visual analog scale (VAS) will be used to assess the pain intensity of individuals related to TMJD. The individual will be asked to mark the perceived pain intensity on a 10 cm long horizontal line. The individual's pain intensity will be recorded by measuring the distance the individual marks on the line in millimeters.

    Time frame: 1 day (The evaluation will be done one-time)

  2. Evaluation of Temporomandibular Joint Functional Status

    Mandibular Dysfunction Questionnaire (MFBA) was administered to individuals to assess the functional status of the joint and the level of functional impairment that its dysfunction may cause.

    Time frame: 1 day (The evaluation will be done one-time)

Secondary outcomes

  1. Measurement of Temporomandibular Joint Mobility

    Individuals will be instructed to open their mouths as wide as possible without causing pain and joint mobility will be measured and recorded using a millimetric ruler. TMJ movements in all directions will be measured three times and the average of the measurements will be recorded and noted.

    Time frame: 1 day (The evaluation will be done one-time)

  2. Immittancemetric Evaluation

    Before tympanometric evaluation, otoscopic examination is performed. Tympanometry, acoustic reflex and eustachian tube function tests are performed with the Interacoustics® Titan Handheld (Denmark) device.

    Time frame: 1 day (The evaluation will be done one-time)

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06722833
Lead sponsor
Uskudar University
Responsible party
FİLİZ EYÜBOĞLU (PhD, Uskudar University) — Principal investigator
First posted
Dec 9, 2024
Start date
Dec 30, 2024 (estimated)
Primary completion
Apr 30, 2025 (estimated)
Completion
May 1, 2025 (estimated)
Last update
Dec 9, 2024

Study contacts

Tuba Kolaylı Çerezci, PhD(c)
Contact
tuba.kolayli@uskudar.edu.tr
(216)4002222
Filiz Eyüboğlu, PhD
principal investigator · Uskudar University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion